Regulatory compliance for private label probiotic eye cream differs significantly by market: the EU and UK require pre-market cosmetics registration and CPNP listing; the U.S. generally treats cosmetics as self-regulated unless they make drug claims; and other markets (Canada, Australia, Japan) have their own frameworks. Non-compliance can result in fines, product seizures, or bans, so clarity upfront is essential.
In the European Union and UK (post-Brexit), an eye cream is classified as a cosmetic under the Cosmetics Regulation (EU 1223/2009) and the UK Cosmetics Regulation. Before you sell the product in these markets, your manufacturer or your company (as the legal "responsible person") must: (1) register the product in the CPNP (Cosmetics Products Notification Portal) with a complete ingredients list in INCI nomenclature, a safety assessment signed by a qualified toxicologist, and a Product Information File (PIF) containing the formula, stability data, preservative efficacy testing, and microbiological testing results; (2) ensure no prohibited or restricted substances are in the formula (e.g., heavy metals above limits, banned colorants); and (3) hold a European responsible person (you or a contracted entity based in the EU/EEA) who is accountable to regulators. CPNP registration is free but requires a detailed PIF; the file should include stability testing at room temperature for the intended shelf life (typically 8–12 weeks accelerated testing as a proxy) and a declaration that probiotic claims (if any) are substantiated. If your eye cream contains a probiotic ferment extract, the extract must be listed in INCI nomenclature (e.g., "Lactobacillus fermentum lysate") and must not be a novel food or novel ingredient without a prior EFSA safety opinion—most common ferment extracts are widely used and have a long history of safe use, so they are accepted, but be cautious if using an obscure or proprietary strain.
Probiotic viability claims ("supports skin microbiome" or "promotes healthy skin flora") are permissible in the EU if substantiated by scientific data, either published peer-reviewed studies or in-house testing. However, claims that imply a medical benefit ("restores disrupted microbiome," "treats dysbiosis," or "prevents infection") cross into drug territory and are prohibited. The line is fine: "promotes a balanced skin microbiome" is acceptable; "treats bacterial overgrowth disease" is not. Efficacy claims must be backed by a dossier of published or in-house data, typically including in vitro studies, clinical studies, or mode-of-action research, and a safety summary. If you make no efficacy claims beyond general moisturization and conditioning, regulatory burden is lower.
The UK has mirrored the EU Cosmetics Regulation post-Brexit, so if you are registered in the CPNP for the EU, you must also register separately with the UK's Cosmetics Notification Portal (SCPN) and designate a UK responsible person. This was a significant additional step for U.K. post-Brexit; before 2021, a single CPNP listing covered both.
In the United States, the FDA does not require pre-market approval for cosmetics; instead, a probiotic eye cream is assumed to be a cosmetic (not a drug) unless it makes a drug claim (e.g., "treats acne," "reduces wrinkles," "repairs barrier function as a drug would"). A probiotic ferment extract or lysate is not an approved or controlled ingredient by the FDA; it is treated as a cosmetic ingredient at the formulator's risk. You do not need to register the formula with the FDA in advance, but you must: (1) ensure the formula does not contain prohibited substances (lead, mercury, banned colorants, formaldehyde donors above limits); (2) comply with facility registration (cosmetics manufacturers must register with the FDA, and foreign manufacturers must register through a U.S. agent); (3) label the product truthfully and not misleadingly (ingredients must be listed in descending order by weight, using INCI names or common names if no INCI exists for an ingredient); and (4) keep a safety file (formula, stability data, safety assessment) at your manufacturing facility or responsible party's office, available for FDA inspection. If a probiotic eye cream claims to "hydrate," "moisturize," or "condition" the eye area, it is a cosmetic claim and permitted. If it claims to "reduce fine lines" or "improve skin elasticity" via wrinkle-reducing action, it is an anti-aging drug claim under FDA guidance (because the FDA considers wrinkle reduction a drug function). The boundary is murky; phrases like "firming" or "lifting" can be interpreted as drug claims if they imply structural change to skin, or cosmetic if they mean visual smoothness.
There is no "probiotic cosmetics" special category in U.S. law, but the FDA has been cautious about live probiotic claims in cosmetics. If you claim live probiotics or CFU counts on a U.S. cosmetic, the product may be viewed as an unapproved drug (a biological product) under 21 CFR 211. Most U.S. brands avoid live-culture claims and instead use ferment extracts labeled as cosmetic ingredients, which sidestep the drug classification issue. If you do use a live-culture format, consult a cosmetics regulatory attorney, because the FDA may challenge the product's legality.
Canada's regulatory framework (CSA, cosmetics and Natural and Non-prescription Health Products Directorate) also requires pre-market notification and a Product License Application for any product claiming health benefits beyond basic cosmetics. A probiotic eye cream claiming only cosmetic benefits (moisturizing, conditioning) can be sold without pre-approval, but a claim like "supports skin microbiome balance" may trigger health claim review. Australia (TGA) similarly classifies cosmetics versus therapeutic goods; a probiotic eye cream is usually cosmetic, but claims implying immune or barrier repair function may be deemed therapeutic.
Key steps to ensure compliance: (1) Work with a manufacturer or regulatory consultant who understands your target markets and can confirm the formula meets local prohibited/restricted substance limits and labeling requirements; (2) Obtain a completed Product Information File (PIF) or safety dossier from the manufacturer, including stability data, preservative efficacy testing, and microbiological testing; (3) For the EU/UK, register the formula in CPNP and SCPN before launch and designate a responsible person; (4) For the U.S., register your manufacturing facility and foreign facility (if applicable) with the FDA and maintain a safety file; (5) Draft claims and labeling carefully, avoiding drug-like language ("treats," "cures," "repairs dysbiosis") and sticking to cosmetic descriptors ("hydrates," "soothes," "supports skin health"); (6) Request third-party verification of any probiotic efficacy or safety claims via published studies or independent lab testing; and (7) Conduct a post-market surveillance plan, monitoring customer feedback and adverse events.
A frequent mistake is assuming that if a probiotic extract is "natural" or "traditionally used," it is automatically safe and compliant. This is false. The EU, U.S., and other markets do not grandfather in ingredients based on history alone; every ingredient and every formula must meet the specific regulatory safety and efficacy thresholds of that market. An ingredient approved in the EU may be prohibited or restricted in the U.S., and vice versa. Similarly, do not assume that stability testing the manufacturer conducted in their own lab meets your market's regulatory expectations; third-party or accredited lab testing carries more weight, especially for claims substantiation.
When working with a private label manufacturer via AJ Cosmo Labs, ask the vetted lab or co-packer upfront which markets they have experience in and what regulatory support they provide: Do they supply a completed PIF for EU/UK registration? Do they maintain a safety dossier compliant with FDA expectations? Do they advise on claim substantiation? Can they recommend a regulatory consultant? Clarity on regulatory responsibility at the start saves time and legal exposure later.
Read the full guide on Private Label Probiotic Eye Cream Manufacturer Low MOQ →